Alzheimer's disease statistics - prevalence and age
Professor Donna Wilcock discusses Alzheimer's disease in the light of increasing prevalence as the population ages.
Alzheimerâ€™s disease is becoming more common, and the reason itâ€™s becoming more common is that basically people are living longer. Itâ€™s still a known fact that the biggest risk factor for Alzheimerâ€™s disease is age. So, by 80 years old, there is a reasonable percentage of the population that have Alzheimerâ€™s at that age. The concern is that as the baby boomer generation starts to hit this age of onset for Alzheimerâ€™s disease, which is basically 75 and up is when we see the increase in disease, that this is going to become a major public health problem. And we are going to have very large numbers by the time we hit 2050.
disease alzheimer, prevalence, statistics, age, baby, boomer, generation, risk, factor, donna, wilcock
An overview of Alzheimer's disease-related content on Genes to Cognition Online.
Professor Donna Wilcock discusses early-onset Alzheimer's disease, which can reach an advanced stage by the age of 50 or 60 years.
Professor Donna Wilcock discusses the late-onset gene for Alzheimer's disease, ApoE4, which increases the risk of developing the disease.
Professor Donna Wilcock discusses research that correlates higher education levels with Alzheimer's disease prevention. This finding has not been fully supported.
Professor Donna Wilcock explains that Alzheimer's disease is diagnosed clinically by a battery of tests that can take a full day to administer.
Professor Donna Wilcock dscusses the cholinergic hypothesis of Alzheimer's disease, which focuses on cholinergic neurons. The hypothesis has not been supported.
Professor Donna Wilcock describes amyloid plaques as clumps of protein in the brain that are one of the three hallmarks of Alzheimer's disease.
Professor Donna Wilcock explains that Aricept can only provide short-term benefit in treating Alzheimer's disease.
Professor Donna Wilcock discusses late-onset Alzheimer's disease, which involves the clearance and/or production of the amyloid beta protein.
In this review of schizophrenia, the authors show how our growing knowledge of causal factors offers hope for successful preventive measures.